Document is current
Any future updates will be listed below
-
Authors
Mahalingasivam, Aksayan Arunanthy https://orcid.org/0000-0003-0406-9702
Vestergaard, Peter
Rasmussen, Nicklas Højgaard-Hessellund
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052064)
DDEA research grant (NNF22SA0079901)
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 8 August 2025
First Online: 24 August 2025
Declarations
:
: ChatGPT was used for optimizing the written academic English and grammar.
: Peter Vestergaard is head of research in the Steno Diabetes Center North Denmark funded by an unrestricted grant from the Novo Nordisk Foundation. Nicklas H. Rasmussen holds shares in Novo Nordisk, has lecture fees from Boehringer Ingelheim and travel expenses from UCB. Aksayan Arunanthy Mahalingasivam has no conflicts of interest to disclose.
